-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs022583-phillips-final-report-2018.pdf
January 01, 2018 - A1c) X X X
0062 (diabetes – urine protein screening) X X X
0064 (diabetes – LDL) X X
0068 (IVD: aspirin … 0.94(0.05) 0.94(0.16)
0064 (diabetes – LDL) 0.91(0.03) 0.94(0.02) 0.91(0.06) 0.92(0.07)
0068 (IVD: aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/r01hs015188-huck-final-report-2008.pdf
January 01, 2008 - Acute Myocardial Infarction (AMI) and Community Acquired Pneumonia (CAP) final measures
AMI CAP
Aspirin … Acute myocardial infarction measures (goal > 90%)
MEASURE
FINAL
EASTERN WA
FINAL
WESTERN WA
Aspirin
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017163-baker-final-report-2011.pdf
January 01, 2011 - male
LDL-C < 100 mg/dL Medical reason, patient reason ,
prescribed high potency statin§
6
Aspirin … disease and age ≥40 years
Antiplatelet drug on active medication list Medical reason, patient reason,
aspirin … during the intervention year were due to a combination of
more patients satisfying the measures (e.g., aspirin … -0.7 NS 2.1 NS (0.08) 3.1 NS (0.09)
LDL-C control 50.9 51.6 56.3 0.8 0.04 4.8 <0.001 4.1 <0.001
Aspirin
-
digital.ahrq.gov/sites/default/files/docs/survey/health-ehearts-physician-survey.pdf
September 28, 2016 - Antithrombotic therapy for patients with ischemic vascular disease (IVD) (e.g. taking prescribed aspirin
-
digital.ahrq.gov/sites/default/files/docs/survey/clinician-survey-quality-improvement.pdf
September 13, 2016 - These guidelines include recommendations on administering Aspirin, Beta blockers,
and thrombolytic agents
-
digital.ahrq.gov/sites/default/files/docs/quality-metrics-transcript-042811.pdf
December 31, 2007 - For other things, for example, here was aspirin prescribing for
patients with lipid-lowering therapy … Aspirin was
often prescribed but since it was an over-the-counter medication it wasn’t recorded on … There is a text box you open up and you can put “intolerant to aspirin, cannot afford
Clopidogrel.” … Aspirin prescribing, again, improved very
dramatically and this was not just documentation. … About half of these at least were clearly new
initiation of aspirin when it had not been before.
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs017059-wu-final-report-2010.pdf
January 01, 2010 - Therapy Ages 18 years or older with Ischemic Vascular Disease or ages 40 years or older with Diabetes on aspirin … within past 24
months
Smoking Status Patients 18+ Smoking status recorded in the past 12
months
Aspirin … Patients 18+ with ischemic vascular
disease or 40+ with diabetes
Taking Aspirin/other Antithrombotic … Patients meeting
quality goal:
Difference
A1c Control 29.4 29.1 -0.3
A1c Screening 45.1 64.9 19.8*
Aspirin
-
digital.ahrq.gov/sites/default/files/docs/resource/final-b14-archives-sarkar2075.pdf
January 01, 2013 - Patient is/is not taking any
anticoagulant drugs (i.e., Coumadin, heparin) or antiplatelet drugs (i.e.,
aspirin … anticoagulant drugs (i.e., Coumadin, heparin) or antiplatelet drugs (i.e.,
13
Rev 12/17/12
aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/appendix-e-cdspain-sample-clinical-practice-guidelines.docx
October 16, 2020 - therapy, relaxation, biofeedback, exercise therapy)
· Avoid migraine triggers
Acute treatments
· Aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/r18hs017046-krist-final-report-2011.pdf
January 01, 2011 - and
osteoporosis; 3 immunizations: tetanus, influenza, and pneumococcal; and 5 counseling services:
aspirin … Chlamydia screening,
pneumococcal vaccination, cholesterol screening, hypertension screening, and aspirin … -
Osteoporosis screening 37.8% 40.0% 0.738 43.6% 49.9% 0.371 45.8% 49.0% 0.663 72.1% 92.7% 0.275
Aspirin … - -- --
Osteoporosis screening 46.2% 54.7% 0.2 38% 52.1% 0.06 37.9% 51.4% 0.073 77.4% 97.6% 0.388
Aspirin
-
digital.ahrq.gov/sites/default/files/docs/page/Nemeth_SuccessStory.pdf
May 02, 2014 - .#) 04/17/2009 05/09/2009
Alcohol 50-64 XeAR old femAle 04/10/2011 W
Aspirin therapy multiple
BP multiple
-
digital.ahrq.gov/sites/default/files/docs/SFQD_Slides%20(2).pdf
January 01, 1993 - adherence with targets
Red, yellow, and green indicators
show adherence with targets
Zero defect care:
• Aspirin … • Beta-blockers
• Blood pressure
• Lipids
Zero defect care:
• Aspirin
• Beta-blockers
• Blood pressure
-
digital.ahrq.gov/sites/default/files/docs/AQAWebConfPresentation%20(1).pdf
July 01, 2010 - INFORMATION
TECHNOLOGY (RHIT) AHRQ GRANT
• Performance Indicators:
– Acute Myocardial Infarction
• Aspirin
-
digital.ahrq.gov/sites/default/files/docs/hit-aging-adults-slides-071717.pdf
July 17, 2017 - Aspirin 81 mg PO QD
9. Zyrtec (Cetirizine) 10 mg PO QD
10.
-
digital.ahrq.gov/sites/default/files/docs/resource/Mostashari_List_of_Measures_TCNY_AQA_eQARR_Crosswalk_1_30_08_Mostashari.pdf
May 29, 2009 - patients with
IVD or DM
Patients >= 18
years of age
with IVD or >=
40 years of age
with DM on
aspirin
-
digital.ahrq.gov/sites/default/files/docs/page/unlocking_quality_information__understanding_the_value_of_health_it_for_quality_measurement_and_improvement_5.pdf
April 26, 2010 - radiology
59
Examples of Clinical Measures
• Diabetes:
• HgA1c control
• Hypertension control
• Aspirin … HgA1C value
LDL value for diabetics and cardiovascular
Blood pressure for diabetics and hypertension
Aspirin
-
digital.ahrq.gov/sites/default/files/docs/publication/p20hs015364-jones-final-report-2005.pdf
January 01, 2005 - research: Current best practices using HIT appears to be narrow focused on
things like getting an aspirin
-
digital.ahrq.gov/sites/default/files/docs/resource/B7_Archives_Pohl_HS17034_1013_1.pdf
February 14, 2011 - LDL < 100
24
Aspirin or
Antithrombotic (%)
MQIC Data
Warehouse
Active Diabetes Patients (see … Diabetes tab)
age >= 40 years
Active Diabetes Patients Age >= 40 years that are currently
taking Aspirin
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-year4-final-report-2020.pdf
January 01, 2020 - No
Abnormal Blood Glucose and Type
2 Diabetes Mellitus: Part Two,
Counseling
No Yes Yes No
Aspirin … abnormal-blood-glucose-and-type-2-diabetes-mellitus-part-two-counseling
https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer … https://cds.ahrq.gov/cdsconnect/artifact/aspirin-therapy-primary-prevention-cvd-and-colorectal-cancer
-
digital.ahrq.gov/sites/default/files/docs/publication/r18hs017037-ornstein-final-report-2010.pdf
January 01, 2010 - • Annual hemoglobin and platelet count for anti-platelets (excluding aspirin) or oral
anticoagulant